BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16526315)

  • 1. The influence of the endothelin-converting enzyme-1 gene polymorphism on the progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Merta M; Stekrová J; Tesar V; Kmentová D; Ríhová Z; Rysavá R; Viklický O
    Ren Fail; 2006; 28(1):21-4. PubMed ID: 16526315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Merta M; Stekrová J; Cabartová Z; Cibulka R; Maixnerová D; Rysavá R; Ríhová Z; Tesar V; Motán J
    Kidney Blood Press Res; 2006; 29(3):182-8. PubMed ID: 16943682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
    Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of G-protein beta3-subunit gene and endothelial nitric oxide synthase gene in exon 7 polymorphisms on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Miroslav M; Stekrová J; Kohoutová M; Tesar V; Kmentová D; Hubácek JA; Viklický O
    Ren Fail; 2004 Mar; 26(2):119-25. PubMed ID: 15287194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease.
    Merta M; Reiterová J; Stekrová J; Rysava R; Rihová Z; Tesar V; Viklický O; Kmentova D
    Kidney Blood Press Res; 2003; 26(1):42-9. PubMed ID: 12697976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of endothelin-A receptor gene polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
    Reiterová J; Merta M; Stekrová J; Maixnerová D; Obeidová H; Kebrdlová V; Viklický O; Tesar V
    Folia Biol (Praha); 2007; 53(4):134-7. PubMed ID: 17706018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD.
    Lee KB; Kim UK
    Yonsei Med J; 2003 Aug; 44(4):641-7. PubMed ID: 12950120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-converting enzyme-1b C-338A polymorphism is associated with the increased risk of coronary artery disease in Chinese population.
    Wang LS; Tang NP; Zhu HJ; Zhou B; Yang L; Wang B
    Clin Chim Acta; 2007 Sep; 384(1-2):75-9. PubMed ID: 17618613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
    Lee KB; Kim UK; Lee CC
    J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
    Merta M; Reiterová J; Tesar V; Stekrová J; Viklický O
    Ren Fail; 2002 Jul; 24(4):467-75. PubMed ID: 12212826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
    Merta M; Reiterová J; Tesar V; Stekrová J; Viklický O
    Ren Fail; 2002 Sep; 24(5):585-93. PubMed ID: 12380903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of endothelin-converting enzyme-1b C-338A polymorphism with gastric cancer risk: a case-control study.
    Gu H; Yang L; Tang N; Zhou B; Zhu H; Sun Q; Cong R; Wang B
    Eur J Cancer; 2008 Jun; 44(9):1253-8. PubMed ID: 17977716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes encoding endothelin-converting enzyme-1 and endothelin-1 interact to influence blood pressure in women: the EVA study.
    Funalot B; Courbon D; Brousseau T; Poirier O; Berr C; Cambien F; Amouyel P; Schwartz JC; Ducimetière P;
    J Hypertens; 2004 Apr; 22(4):739-43. PubMed ID: 15126915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of endothelin-converting enzyme-1b C-338A polymorphism with increased risk of ischemic stroke in Chinese Han population.
    Li R; Cui M; Zhao J; Yu M; Ying Z; Zhou S; Zhou H
    J Mol Neurosci; 2013 Oct; 51(2):485-92. PubMed ID: 24026618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor as an angiogenesis biomarker for the progression of autosomal dominant polycystic kidney disease.
    Martins DP; Souza MA; Baitello ME; Nogueira V; Oliveira CI; Pinhel MA; Caldas HC; Filho MA; Souza DR
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-338A polymorphism of the endothelin-converting enzyme (ECE-1) gene and the susceptibility to sporadic late-onset Alzheimer's disease and coronary artery disease.
    Scacchi R; Gambina G; Broggio E; Ruggeri M; Corbo RM
    Dis Markers; 2008; 24(3):175-9. PubMed ID: 18334739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifier effect of the Glu298Asp polymorphism of endothelial nitric oxide synthase gene in autosomal-dominant polycystic kidney disease.
    Stefanakis N; Ziroyiannis P; Trygonis S; Lamnissou K
    Nephron Clin Pract; 2008; 110(2):c101-6. PubMed ID: 18815450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifier effect of ENOS in autosomal dominant polycystic kidney disease.
    Persu A; Stoenoiu MS; Messiaen T; Davila S; Robino C; El-Khattabi O; Mourad M; Horie S; Feron O; Balligand JL; Wattiez R; Pirson Y; Chauveau D; Lens XM; Devuyst O
    Hum Mol Genet; 2002 Feb; 11(3):229-41. PubMed ID: 11823442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease.
    Pérez-Oller L; Torra R; Badenas C; Milà M; Darnell A
    Am J Kidney Dis; 1999 Aug; 34(2):273-8. PubMed ID: 10430974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-338A polymorphism of the endothelin-converting enzyme-1 gene and the susceptibility to carotid atherosclerosis.
    Jin Z; Luxiang C; Huadong Z; Zhiqiang X; Lihua H; Huiyun L
    Microvasc Res; 2009 Jun; 78(1):128-31. PubMed ID: 19289136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.